Zhao Z - Search Results

1

SIRT2 Promotes the Migration and Invasion of Gastric Cancer through RAS/ERK/JNK/MMP-9 Pathway by Increasing PEPCK1-Related Metabolism.

Li Y, Zhang M, Dorfman RG, Pan Y, Tang D, Xu L, Zhao Z, Zhou Q, Zhou L, Wang Y, Yin Y, Shen S, Kong B, Friess H, Zhao S, Wang L, Zou X. Li Y, et al. Among authors: zhao z, zhao s. Neoplasia. 2018 Jul;20(7):745-756. doi: 10.1016/j.neo.2018.03.008. Epub 2018 Jun 17. Neoplasia. 2018. PMID: 29925042 Free PMC article.

2

Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition.

Yin Y, Zhang M, Dorfman RG, Li Y, Zhao Z, Pan Y, Zhou Q, Huang S, Zhao S, Yao Y, Zou X. Yin Y, et al. Among authors: zhao z, zhao s. Cell Death Dis. 2017 Jun 1;8(6):e2856. doi: 10.1038/cddis.2016.457. Cell Death Dis. 2017. PMID: 28569784 Free PMC article.

3

Downregulation of SIRT2 Inhibits Invasion of Hepatocellular Carcinoma by Inhibiting Energy Metabolism.

Huang S, Zhao Z, Tang D, Zhou Q, Li Y, Zhou L, Yin Y, Wang Y, Pan Y, Dorfman RG, Ling T, Zhang M. Huang S, et al. Among authors: zhao z. Transl Oncol. 2017 Dec;10(6):917-927. doi: 10.1016/j.tranon.2017.09.006. Epub 2017 Oct 17. Transl Oncol. 2017. PMID: 28992545 Free PMC article.

4

Thiomyristoyl ameliorates colitis by blocking the differentiation of Th17 cells and inhibiting SIRT2-induced metabolic reprogramming.

Xu Y, Cai R, Zhao Z, Zhou L, Zhou Q, Hassan S, Huang S, Zhang M, Xu G, Zou X. Xu Y, et al. Among authors: zhao z. Int Immunopharmacol. 2021 Jan;90:107212. doi: 10.1016/j.intimp.2020.107212. Epub 2020 Dec 11. Int Immunopharmacol. 2021. PMID: 33310666 Free article.

5

lncRNA GAS5 inhibits colorectal cancer cell proliferation via the miR‑182‑5p/FOXO3a axis.

Cheng K, Zhao Z, Wang G, Wang J, Zhu W. Cheng K, et al. Among authors: zhao z. Oncol Rep. 2018 Oct;40(4):2371-2380. doi: 10.3892/or.2018.6584. Epub 2018 Jul 20. Oncol Rep. 2018. PMID: 30066886

6

PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3.

Chen D, Zhao Z, Chen L, Li Q, Zou J, Liu S. Chen D, et al. Among authors: zhao z. Cell Death Dis. 2021 Jul 21;12(8):722. doi: 10.1038/s41419-021-04013-y. Cell Death Dis. 2021. PMID: 34290239 Free PMC article.

7

Decreased FOXF1 promotes hepatocellular carcinoma tumorigenesis, invasion, and stemness and is associated with poor clinical outcome.

Zhao ZG, Wang DQ, Hu DF, Li YS, Liu SH. Zhao ZG, et al. Onco Targets Ther. 2016 Mar 23;9:1743-52. doi: 10.2147/OTT.S95002. eCollection 2016. Onco Targets Ther. 2016. PMID: 27042124 Free PMC article.

8

LncRNA FEZF1-AS1 Promotes Multi-Drug Resistance of Gastric Cancer Cells via Upregulating ATG5.

Gui Z, Zhao Z, Sun Q, Shao G, Huang J, Zhao W, Kuang Y. Gui Z, et al. Among authors: zhao z, zhao w. Front Cell Dev Biol. 2021 Nov 1;9:749129. doi: 10.3389/fcell.2021.749129. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34790665 Free PMC article.

9

TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network.

Chen D, Zou J, Zhao Z, Tang X, Deng Z, Jia J, Liu S. Chen D, et al. Among authors: zhao z. Cell Death Dis. 2018 Oct 31;9(11):1110. doi: 10.1038/s41419-018-1150-4. Cell Death Dis. 2018. PMID: 30382079 Free PMC article.

10

Long non-coding RNA MALAT1 activates autophagy and promotes cell proliferation by downregulating microRNA-204 expression in gastric cancer.

Shao G, Zhao Z, Zhao W, Hu G, Zhang L, Li W, Xing C, Zhang X. Shao G, et al. Among authors: zhao z, zhao w. Oncol Lett. 2020 Jan;19(1):805-812. doi: 10.3892/ol.2019.11184. Epub 2019 Dec 4. Oncol Lett. 2020. PMID: 31897197 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,135 results

Search Page

Filters